Want to see KREF full AI Analyst Report?
EarningsQ2 2026 Earnings Report
KREF Q2 2026 EPS Results
Actual EPS-$0.58
Consensus EPS-$0.56
Beat/MissMissed by -$0.02
One Year Ago EPS-$0.04
KREF Q2 2026 Revenue Results
Actual Revenue$91.07M
Expected Revenue$24.97M
Beat/MissBeat by +$66.10M
YoY Revenue Growth-23.18%
Earnings Announcement Details
QuarterQ2 2026
Date07/21/2026
TimeAfter Close
Conference CallTuesday, July 21, 2026
KREF Upcoming Earnings
Kkr Real Estate Finance's next earnings date is estimated for October 26, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
KREF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed a mixed but constructive tone: management reported meaningful operational progress on portfolio repositioning (liquidity generation from repayments, life science modifications, rising new-vintage exposure, targeted asset monetizations and accretive buybacks) while also acknowledging significant near-term headwinds (a GAAP loss, distributable loss, a 13.7% quarter book value decline, material watch list and REO balances, elevated leverage and several credit downgrades). Management believes the most significant book value impact is behind them and outlined clear targets and liquidity to execute the plan, but substantial execution risk and near-term uncertainty remain (including an active strategic review).Company Guidance
Liquidity and Financing Availability
KREF had over $700 million of liquidity at quarter end, including $83 million cash and $350 million undrawn revolver; total financing availability of $7 billion with $2.6 billion undrawn capacity and 79% of financing non-mark-to-market.
Strong Repayment Activity Generating Liquidity
Received over $800 million of repayments during the quarter and approximately $1.2 billion through the first half of 2026; management expects total repayments to exceed $2 billion in 2026 (representing >35% of the portfolio size at the beginning of the year).
Dividend Coverage and Distributable Earnings
Reported distributable earnings before realized losses of $6 million, or $0.10 per share, covering the quarterly $0.10 cash dividend; management continues to expect $0.40 per year of dividend to be covered by annual distributable earnings before realized losses as the business plan executes.
Portfolio Repositioning Progress — New Vintage Increase
Loans originated between 2024 and 2026 now represent ~32% of the portfolio versus 19% at 2025 year-end (increase of ~13 percentage points, ~68% relative increase), with a target to exceed 50% by year-end 2026.
Reduction in Legacy Office Exposure
Legacy office exposure declined to 18% of the portfolio as of June 30 from 21% at year-end 2025 (3 percentage point reduction); target is to reduce legacy office exposure below 10% by year-end 2026.
Life Science Portfolio Actions
Life Science exposure modifications increased to 39% (from ~19% at 2025 year-end), a ~20 percentage point change; management believes the vast majority of expected reserves for Life Science have been recognized and expects to address substantially all Life Science exposure by year-end.
Active Originations and Selective Underwriting
Originated three loans during the quarter totaling approximately $350 million with a weighted average LTV of 58%, demonstrating continued selective new lending activity.
Share Repurchases and Book Value Accretion
Repurchased $38 million of common stock during the quarter at a weighted average price of $6.63, generating approximately $0.32 per share of book value accretion; subsequent post-quarter repurchase of $10 million at $7.24 per share (total repurchases announced $48 million).
KREF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed